Drug Enforcement Administration 2024 – Federal Register Recent Federal Regulation Documents

Janet S. Pettyjohn, D.O.; Decision and Order
Document Number: 2024-23511
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
William J. Mack, M.D.; Decision and Order
Document Number: 2024-23515
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
Robert P. Hansen, M.D.; Decision and Order
Document Number: 2024-23514
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
Michael Berman, D.O.; Decision and Order
Document Number: 2024-23513
Type: Notice
Date: 2024-10-11
Agency: Drug Enforcement Administration, Department of Justice
Midtown Specialty RX; Decision and Order
Document Number: 2024-23482
Type: Notice
Date: 2024-10-10
Agency: Drug Enforcement Administration, Department of Justice
Halowells Pharmacy; Decision and Order
Document Number: 2024-23495
Type: Notice
Date: 2024-10-10
Agency: Drug Enforcement Administration, Department of Justice
Salman Akbar, M.D.; Decision and Order
Document Number: 2024-23504
Type: Notice
Date: 2024-10-10
Agency: Drug Enforcement Administration, Department of Justice
Merry Alice Troupe, N.P.; Decision and Order
Document Number: 2024-23170
Type: Notice
Date: 2024-10-08
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Fresenius Kabi USA, LLC
Document Number: 2024-22450
Type: Notice
Date: 2024-10-01
Agency: Drug Enforcement Administration, Department of Justice
Fresenius Kabi USA, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Curia Wisconsin, Inc.
Document Number: 2024-22446
Type: Notice
Date: 2024-10-01
Agency: Drug Enforcement Administration, Department of Justice
Curia Wisconsin, Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Adam L. Larson, M.D.; Decision and Order
Document Number: 2024-22191
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Wagner Gervais, P.A.; Decision and Order
Document Number: 2024-22190
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Michael Fletcher, M.D.; Decision and Order
Document Number: 2024-22205
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Lawrence Rudolph, D.M.D.; Decision and Order
Document Number: 2024-22204
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Charles Sangmoah, P.A.; Decision and Order
Document Number: 2024-22202
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Theodore S. Wright Jr., M.D.; Decision and Order
Document Number: 2024-22200
Type: Notice
Date: 2024-09-27
Agency: Drug Enforcement Administration, Department of Justice
Proposed Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2025
Document Number: 2024-21962
Type: Notice
Date: 2024-09-25
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration (DEA) proposes to establish the 2025 aggregate production quotas for controlled substances in schedules I and II of the Controlled Substances Act (CSA) and the assessment of annual needs for the list I chemicals ephedrine, pseudoephedrine, and phenylpropanolamine.
Proposed Adjustments to the Aggregate Production Quotas for Schedule I and II Controlled Substances and Assessment of Annual Needs for the List I Chemicals Ephedrine, Pseudoephedrine, and Phenylpropanolamine for 2024
Document Number: 2024-21960
Type: Notice
Date: 2024-09-25
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration proposes to adjust the 2024 aggregate production quotas for several controlled substances in schedules I and II of the Controlled Substances Act. Additionally, as DEA announced in an April 29, 2024 letter to DEA-registered manufacturers, procurement quotas for commercial manufacturing of a schedule II controlled substance will be calculated on a semi-annual basis, except for injectable drug products containing schedule II controlled substances, which will be calculated on an annual basis.
Importer of Controlled Substances Application: Curium US LLC
Document Number: 2024-21850
Type: Notice
Date: 2024-09-25
Agency: Drug Enforcement Administration, Department of Justice
Curium US LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Chemtos, LLC
Document Number: 2024-21062
Type: Notice
Date: 2024-09-17
Agency: Drug Enforcement Administration, Department of Justice
Chemtos, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Eli-Elsohly Laboratories
Document Number: 2024-21060
Type: Notice
Date: 2024-09-17
Agency: Drug Enforcement Administration, Department of Justice
Eli-Elsohly Laboratories has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Schedules of Controlled Substances: Temporary Placement of N-Pyrrolidino Metonitazene and N-Pyrrolidino Protonitazene in Schedule I
Document Number: 2024-21058
Type: Proposed Rule
Date: 2024-09-17
Agency: Drug Enforcement Administration, Department of Justice
The Administrator of the Drug Enforcement Administration is issuing this notice of intent to publish a temporary order to schedule two synthetic benzimidazole-opioid substances, N-pyrrolidino metonitazene and N-pyrrolidino protonitazene, including their isomers, esters, ethers, salts, and salts of isomers, esters, and ethers whenever the existence of such isomers, esters, ethers, and salts is possible, in schedule I of the Controlled Substances Act. When it is issued, the temporary scheduling order will impose the regulatory controls and administrative, civil, and criminal sanctions applicable to schedule I controlled substances on persons who handle (manufacture, distribute, reverse distribute, import, export, engage in research, conduct instructional activities or chemical analysis, or possess) or propose to handle these two specified substances.
George D. Gowder, III, M.D.; Decision and Order
Document Number: 2024-21051
Type: Notice
Date: 2024-09-17
Agency: Drug Enforcement Administration, Department of Justice
Mary A. Vreeke, M.D.; Decision and Order
Document Number: 2024-20939
Type: Notice
Date: 2024-09-16
Agency: Drug Enforcement Administration, Department of Justice
Awesome Care Pharmacy, Inc.; Decision and Order
Document Number: 2024-20937
Type: Notice
Date: 2024-09-16
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Purisys, LLC
Document Number: 2024-20935
Type: Notice
Date: 2024-09-16
Agency: Drug Enforcement Administration, Department of Justice
Purisys, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Curia New York, Inc.
Document Number: 2024-20193
Type: Notice
Date: 2024-09-09
Agency: Drug Enforcement Administration, Department of Justice
Curia New York, Inc. has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Curia New York, Inc.
Document Number: 2024-20192
Type: Notice
Date: 2024-09-09
Agency: Drug Enforcement Administration, Department of Justice
Curia New York, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Document Number: 2024-20082
Type: Notice
Date: 2024-09-06
Agency: Drug Enforcement Administration, Department of Justice
Cambridge Isotope Laboratories, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Biopharmaceutical Research Company
Document Number: 2024-20085
Type: Notice
Date: 2024-09-06
Agency: Drug Enforcement Administration, Department of Justice
Biopharmaceutical Research Company has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Importer of Controlled Substances Application: Bright Green Corporation
Document Number: 2024-20083
Type: Notice
Date: 2024-09-06
Agency: Drug Enforcement Administration, Department of Justice
Bright Green Corporation has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Adjustment to the Aggregate Production Quota for Lisdexamfetamine and d-Amphetamine (for Conversion) for 2024
Document Number: 2024-20114
Type: Notice
Date: 2024-09-05
Agency: Drug Enforcement Administration, Department of Justice
The Drug Enforcement Administration is adjusting the 2024 aggregate production quota for the schedule II controlled substances lisdexamfetamine and d-amphetamine (for conversion). In making this determination, DEA has considered the factors set forth in its regulations in accordance with the statutes and is expediting publication of this determination to comply with the timeframes specified in the statutes.
Bulk Manufacturer of Controlled Substances Application: Benuvia Operations, LLC
Document Number: 2024-19795
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Benuvia Operations, LLC has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Continuus Pharmaceuticals
Document Number: 2024-19756
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Continuus Pharmaceuticals has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Indivior Inc.
Document Number: 2024-19754
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Indivior Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Biopharmaceutical Research Company
Document Number: 2024-19783
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Biopharmaceutical Research Company has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to SUPPLEMENTARY INFORMATION listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals, Inc.
Document Number: 2024-19779
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Chattem Chemicals, Inc., has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Bright Green Corporation
Document Number: 2024-19777
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Bright Green Corporation has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Catalent CTS, LLC
Document Number: 2024-19776
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Catalent CTS, LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Samirkumar Shah, M.D.; Decision and Order
Document Number: 2024-19731
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
Document Number: 2024-19791
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Fisher Clinical Services, Inc. has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cambrex High Point, Inc
Document Number: 2024-19790
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Cambrex High Point, Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Chattem Chemicals
Document Number: 2024-19789
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Chattem Chemicals has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Bulk Manufacturer of Controlled Substances Application: Cambridge Isotope Laboratories, Inc.
Document Number: 2024-19788
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Cambridge Isotope Laboratories, Inc has applied to be registered as a bulk manufacturer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Amneal Complex Products Research LLC
Document Number: 2024-19787
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Amneal Complex Products Research LLC has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Importer of Controlled Substances Application: Caligor Coghlan Pharma Services
Document Number: 2024-19785
Type: Notice
Date: 2024-09-04
Agency: Drug Enforcement Administration, Department of Justice
Caligor Coghlan Pharma Services has applied to be registered as an importer of basic class(es) of controlled substance(s). Refer to Supplementary Information listed below for further drug information.
Stephen McCarthy, P.A.; Decision and Order
Document Number: 2024-19730
Type: Notice
Date: 2024-09-03
Agency: Drug Enforcement Administration, Department of Justice
Schedules of Controlled Substances: Rescheduling of Marijuana
Document Number: 2024-19370
Type: Proposed Rule
Date: 2024-08-29
Agency: Drug Enforcement Administration, Department of Justice
This is notice that the Drug Enforcement Administration will hold a hearing with respect to the proposed rescheduling of marijuana into schedule III of the Controlled Substances Act. The proposed rescheduling of marijuana was initially proposed in a Notice of Proposed Rulemaking published in the Federal Register on May 21, 2024.
Irene Kimura, M.D.; Decision and Order
Document Number: 2024-18100
Type: Notice
Date: 2024-08-14
Agency: Drug Enforcement Administration, Department of Justice
Thomas M. Fausset, O.D.; Decision and Order
Document Number: 2024-18096
Type: Notice
Date: 2024-08-14
Agency: Drug Enforcement Administration, Department of Justice
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.